Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation
- PMID: 177195
Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation
Abstract
Estrogen and prolactin receptor concentrations were measured in 24 carcinogen-induced rat mammary tumors and correlated with the tumor response to host ovariectomy or hypophysectomy. It was found that essentially all of the tumors contained some specific estrogen receptor, and all but three contained prolactin receptor. The values for each receptor comprised a continuum from very low to relatively high concentrations, suggesting that previous considerations of hormone dependence on the basis of presence or absence of hormone receptors may be oversimplified. The concentration of each receptor tended to be lower in the hormone-independent than in the hormone-dependent tumors, but there were a number of hormone-independent tumors with higher receptor levels than some of the hormone-dependent tumors had. A better correlation of tumor response to endocrine ablation resulted from a combination of the 2 receptor levels than from either receptor concentration alone. These results suggest that there is a complex relationship between mammary tumor response to endocrine ablatin and levels of estrogen and prolactin receptors and that some tumors may be dependent upon 1 or both of these hormones for growth.
Similar articles
-
Prolactin receptors in 7,12-dimethylbenz(a) anthracene-induced mammary tumors following endocrine ablation.Cancer Res. 1976 Nov;36(11 Pt 1):3941-3. Cancer Res. 1976. PMID: 184919
-
Prolactin and breast carcinoma.N Engl J Med. 1975 Apr 10;292(15):784-92. doi: 10.1056/NEJM197504102921506. N Engl J Med. 1975. PMID: 1089886 Review.
-
Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.Cancer Res. 1976 Feb;36(2 Pt 1):319-24. Cancer Res. 1976. PMID: 816459
-
Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.Cancer Res. 1976 Oct;36(10):3736-41. Cancer Res. 1976. PMID: 133755
-
Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review).Anticancer Res. 1983 Jul-Aug;3(4):273-81. Anticancer Res. 1983. PMID: 6309070 Review.
Cited by
-
Prolactin receptors: a comparison between chloramine-T and lactoperoxidase iodination.J Endocrinol Invest. 1978 Jul;1(3):233-8. doi: 10.1007/BF03350386. J Endocrinol Invest. 1978. PMID: 229147
-
Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.Br J Cancer. 1977 May;35(5):602-9. doi: 10.1038/bjc.1977.94. Br J Cancer. 1977. PMID: 405032 Free PMC article.
-
Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.In Vitro Cell Dev Biol Anim. 2000 Jul-Aug;36(7):410-27. doi: 10.1290/1071-2690(2000)036<0410:EMAIDO>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2000. PMID: 11039493
-
Hormonal status and steroid metabolism in two transplantable rat mammary tumours.Br J Cancer. 1979 Feb;39(2):200-4. doi: 10.1038/bjc.1979.32. Br J Cancer. 1979. PMID: 155467 Free PMC article. No abstract available.
-
Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study.Br J Cancer. 1990 Oct;62(4):643-6. doi: 10.1038/bjc.1990.346. Br J Cancer. 1990. PMID: 2223582 Free PMC article. Clinical Trial.